207 related articles for article (PubMed ID: 9097264)
1. Relationship between hepatocyte proliferation and hepatitis delta virus replication in neoplastic and non-neoplastic liver tissues.
Negro F; Papotti M; Taraglio S; Rubbia-Brandt L; Giostra E; Pacchioni D; Rizzetto M; Hadengue A
J Viral Hepat; 1997 Mar; 4(2):93-8. PubMed ID: 9097264
[TBL] [Abstract][Full Text] [Related]
2. Proteomic changes in HEK-293 cells induced by hepatitis delta virus replication.
Mendes M; Pérez-Hernandez D; Vázquez J; Coelho AV; Cunha C
J Proteomics; 2013 Aug; 89():24-38. PubMed ID: 23770296
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis delta virus replication and the role of the small hepatitis delta protein S-HDAg].
Abeywickrama-Samarakoon N; Cortay JC; Sureau C; Alfaiate D; Levrero M; Dény P
Med Sci (Paris); 2018 Oct; 34(10):833-841. PubMed ID: 30451678
[TBL] [Abstract][Full Text] [Related]
4. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
5. Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Diaz G; Engle RE; Tice A; Melis M; Montenegro S; Rodriguez-Canales J; Hanson J; Emmert-Buck MR; Bock KW; Moore IN; Zamboni F; Govindarajan S; Kleiner DE; Farci P
Mol Cancer Res; 2018 Sep; 16(9):1406-1419. PubMed ID: 29858376
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis D Virus and Hepatocellular Carcinoma.
Farci P; Niro GA; Zamboni F; Diaz G
Viruses; 2021 May; 13(5):. PubMed ID: 34064419
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis delta virus: Replication and pathogenesis.
Sureau C; Negro F
J Hepatol; 2016 Apr; 64(1 Suppl):S102-S116. PubMed ID: 27084031
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of WHV-HDV replication in acute fatal course of woodchuck hepatitis.
D'Ugo E; Canitano A; Catone S; Argentini C; Giuseppetti R; Orobello S; Palmieri G; Rapicetta M
Arch Virol; 2008; 153(11):2069-76. PubMed ID: 18985276
[TBL] [Abstract][Full Text] [Related]
9. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
[TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
[TBL] [Abstract][Full Text] [Related]
11. Innate immune recognition and modulation in hepatitis D virus infection.
Jung S; Altstetter SM; Protzer U
World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review.
Baskiran A; Atay A; Baskiran DY; Akbulut S
J Gastrointest Cancer; 2021 Dec; 52(4):1192-1197. PubMed ID: 34611832
[TBL] [Abstract][Full Text] [Related]
13. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.
Giersch K; Helbig M; Volz T; Allweiss L; Mancke LV; Lohse AW; Polywka S; Pollok JM; Petersen J; Taylor J; Dandri M; Lütgehetmann M
J Hepatol; 2014 Mar; 60(3):538-44. PubMed ID: 24280293
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis delta virus infects the cells of hepadnavirus-induced hepatocellular carcinoma in woodchucks.
Freitas N; Salisse J; Cunha C; Toshkov I; Menne S; Gudima SO
Hepatology; 2012 Jul; 56(1):76-85. PubMed ID: 22334419
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
16. An update on HDV: virology, pathogenesis and treatment.
Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
[TBL] [Abstract][Full Text] [Related]
17. Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA.
Gudima S; Chang J; Moraleda G; Azvolinsky A; Taylor J
J Virol; 2002 Apr; 76(8):3709-19. PubMed ID: 11907210
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis delta virus and hepatocellular carcinoma: an update.
Romeo R; Petruzziello A; Pecheur EI; Facchetti F; Perbellini R; Galmozzi E; Khan NU; Di Capua L; Sabatino R; Botti G; Loquercio G
Epidemiol Infect; 2018 Oct; 146(13):1612-1618. PubMed ID: 29991359
[TBL] [Abstract][Full Text] [Related]
19. Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).
Veloso Alves Pereira I; Buchmann B; Sandmann L; Sprinzl K; Schlaphoff V; Döhner K; Vondran F; Sarrazin C; Manns MP; Pinto Marques Souza de Oliveira C; Sodeik B; Ciesek S; von Hahn T
PLoS One; 2015; 10(2):e0117152. PubMed ID: 25646622
[TBL] [Abstract][Full Text] [Related]
20. High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta.
Romeo R; Foglieni B; Casazza G; Spreafico M; Colombo M; Prati D
PLoS One; 2014; 9(3):e92062. PubMed ID: 24658127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]